GlassScriptPhysician profile
Ernest C Hymel
NPI 1851390819
$2,596.39
in general payments reported to CMS, 2019-2025
51 companies · $443 in 2025
The $443 reported for 2025 was more than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $537 · 2020: $101 · 2021: $79.23 · 2022: $456 · 2023: $523 · 2024: $457 · 2025: $443.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,422.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,422.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Varian Medical Systems, INC. | $275.43 | 2019 | |
| Janssen Biotech, INC. | $155.47 | 2022-2025 | Rybrevant, Erleada |
| Merck Sharp & Dohme LLC | $153.34 | 2022-2025 | Keytruda, Lynparza, Welireg |
| Incyte Corporation | $125.27 | 2019-2025 | Jakafi, Niktimvo |
| Novartis Pharmaceuticals Corporation | $118.28 | 2019-2024 | |
| Jazz Pharmaceuticals INC. | $108.06 | 2021-2025 | |
| Lilly USA, LLC | $102.69 | 2020-2025 | Verzenio, Jaypirca |
| Daiichi Sankyo INC. | $89.68 | 2019-2025 | Enhertu |
| Astrazeneca Pharmaceuticals LP | $81.65 | 2022-2024 | Imfinzi, Tagrisso |
| Pfizer INC. | $79.51 | 2023-2025 | |
| Stemline Therapeutics INC. | $78.27 | 2023-2025 | Orserdu |
| Rigel Pharmaceuticals, INC. | $78.06 | 2020-2025 | Tavalisse, Rezlidhia, Gavreto |
| Genzyme Corporation | $77.60 | 2019-2025 | |
| Abbvie INC. | $68.43 | 2019-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $64.18 | 2019-2023 | Alunbrig |
Show all 51 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ernest Hymel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.